Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines

被引：53

作者：

Wierda, William G. ^{[1
]}

Brown, Jennifer ^{[2
]}

Abramson, Jeremy S. ^{[3
]}

Awan, Farrukh ^{[4
]}

Bilgrami, Syed F. ^{[5
]}

Bociek, Greg ^{[6
]}

Brander, Danielle ^{[7
]}

Chanan-Khan, Asher A. ^{[8
]}

Coutre, Steve E. ^{[9
]}

Davis, Randall S. ^{[10
]}

Eradat, Herbert ^{[11
]}

Fletcher, Christopher D. ^{[12
]}

Gaballa, Sameh ^{[13
]}

Ghobadi, Armin ^{[14
,15
]}

Hamid, Muhammad Saad ^{[16
]}

Hernandez-Ilizaliturri, Francisco ^{[17
]}

Hill, Brian ^{[18
,19
]}

Kaesberg, Paul ^{[20
]}

Kamdar, Manali ^{[21
]}

Kaplan, Lawrence D. ^{[22
]}

Khan, Nadia ^{[23
]}

Kipps, Thomas J. ^{[24
]}

Ma, Shuo ^{[25
]}

Mato, Anthony ^{[26
]}

Mosse, Claudio ^{[27
]}

Schuster, Stephen ^{[28
]}

Siddiqi, Tanya ^{[29
]}

Stephens, Deborah M. ^{[30
]}

Ujjani, Chaitra ^{[31
]}

Wagner-Johnston, Nina ^{[32
]}

Woyach, Jennifer A. ^{[33
]}

Ye, J. Christine ^{[34
]}

Dwyer, Mary A. ^{[35
]}

Sundar, Hema ^{[35
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[5] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[6] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[7] Duke Canc Inst, Durham, NC USA

[8] Mayo Clin, Canc Ctr, Rochester, MN USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] ONeal Comprehens Canc Ctr UAB, Birmingham, AL USA

[11] UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[12] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[15] Washington Univ, Sch Med, St Louis, MO USA

[16] Univ Tennessee, Hlth Sci Ctr, St Jude Chidrens Res Hosp, Knoxville, TN 37996 USA

[17] Roswel Pk Comprehens Canc Ctr, Buffalo, NY USA

[18] Univ Hosp Seidman Canc Ctr, Case Comprehensve Canc Ctr, Cleveland, OH USA

[19] Cleveland Clin, Tausslg Canc Inst, Cleveland, OH 44106 USA

[20] UC Davis Comprehens Canc Ctr, Davis, CA USA

[21] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[22] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[23] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[24] UC San Diego Moores Canc Ctr, San Diego, CA USA

[25] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[26] Mem Sloan Kettering Canc Ctr, Ithaca, NY USA

[27] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[28] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[29] City Hope Natl Med Ctr, Duarte, CA USA

[30] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[31] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA

[32] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[33] Ohio State Univ, Comprehenslve Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[34] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[35] Natl Comprehens Canc Network, Philadelphia, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 06期

关键词：

MINIMAL RESIDUAL DISEASE; CHLORAMBUCIL PLUS OBINUTUZUMAB; FLOW-CYTOMETRY; OPEN-LABEL; 1ST-LINE TREATMENT; FOLLOW-UP; PHASE-II; IBRUTINIB; VENETOCLAX; CLL;

D O I：

10.6004/jnccn.2022.0031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton???s tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors has emerged as an effective chemotherapy-free option for patients with previously untreated or relapsed/refractory CLL/SLL. Undetectable minimal residual disease after the end of treatment is emerging as an important predictor of progression-free and overall survival for patients treated with fixed-duration BCL-2 inhibitor-based treatment. These NCCN Guidelines Insights discuss the updates to the NCCN Guidelines for CLL/ SLL specific to the use of chemotherapy-free treatment options for patients with treatment-na??ve and relapsed/refractory disease.

引用

页码：622 / 634

页数：13

共 50 条

[41] NCCN Guidelines® Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines
Biermann, J. Sybil
Chow, Warren
Reed, Damon R.
Lucas, David
Adkins, Douglas R.
Agulnik, Mark
Benjamin, Robert S.
Brigman, Brian
Budd, G. Thomas
Curry, William T.
Didwania, Aarati
Fabbri, Nicola
Hornicek, Francis J.
Kuechle, Joseph B.
Lindskog, Dieter
Mayerson, Joel
McGarry, Sean V.
Million, Lynn
Morris, Carol D.
Movva, Sujana
O'Donnell, Richard J.
Randall, R. Lor
Rose, Peter
Santana, Victor M.
Satcher, Robert L.
Schwartz, Herbert
Siegel, Herrick J.
Thornton, Katherine
Villalobos, Victor
Bergman, Mary Anne
Scavone, Jillian L.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (02): : 155 - 167
[42] NCCN Guidelines® Insights Multiple Myeloma, Version 3.2018 Featured Updates to the NCCN Guidelines
Kumar, Shaji K.
Callander, Natalie S.
Alsina, Melissa
Atanackovic, Djordje
Biermann, J. Sybil
Castillo, Jorge
Chandler, Jason C.
Costello, Caitlin
Faiman, Matthew
Fung, Henry C.
Godby, Kelly
Hofmeister, Craig
Holmberg, Leona
Holstein, Sarah
Huff, Carol Ann
Kang, Yubin
Kassim, Adetola
Liedtke, Michaela
Malek, Ehsan
Martin, Thomas
Neppalli, Vishala T.
Omel, James
Raje, Noopur
Singhal, Seema
Somlo, George
Stockerl-Goldstein, Keith
Weber, Donna
Yahalom, Joachim
Kumar, Rashmi
Shead, Dorothy A.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (01): : 11 - 20
[43] NCCN Guidelines® Insights Hepatobiliary Cancers, Version 1.2017 Featured Updates to the NCCN Guidelines
Benson, Al B., III
D'Angelica, Michael I.
Abbott, Daniel E.
Abrams, Thomas A.
Alberts, Steven R.
Saenz, Daniel Anaya
Are, Chandrakanth
Brown, Daniel B.
Chang, Daniel T.
Covey, Anne M.
Hawkins, William
Iyer, Renuka
Jacob, Rojymon
Karachristos, Andrea
Kelley, R. Kate
Kim, Robin
Palta, Manisha
Park, James O.
Sahai, Vaibhav
Schefter, Tracey
Schmidt, Carl
Sicklick, Jason K.
Singh, Gagandeep
Sohal, Davendra
Stein, Stacey
Tian, G. Gary
Vauthey, Jean-Nicolas
Venook, Alan P.
Zhu, Andrew X.
Hoffmann, Karin G.
Darlow, Susan
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (05): : 563 - 573
[44] Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013 Featured Updates to the NCCN Guidelines
Anderson, Kenneth C.
Alsina, Melissa
Bensinger, William
Biermann, J. Sybil
Cohen, Adam D.
Devine, Steven
Djulbegovic, Benjamin
Faber, Edward A., Jr.
Gasparetto, Christine
Hernandez-Ilizaliturri, Francisco
Huff, Carol Ann
Kassim, Adetola
Krishnan, Amrita Y.
Medeiros, Bruno C.
Meredith, Ruby
Raje, Noopur
Schriber, Jeffrey
Singhal, Seema
Somlo, George
Stockerl-Goldstein, Keith
Treon, Steven P.
Tricot, Guido
Weber, Donna M.
Yahalom, Joachim
Yunus, Furhan
Kumar, Rashmi
Shead, Dorothy A.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1211 - 1219
[45] Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
Jelloul, Fatima Zahra
Chen, Qiang Hua
Yang, Tianyu
Brody, Judith
Zhang, Xinmin
Fayyaz, Silvat Sheikh
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A116 - A116
[46] Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Tempero, Margaret A.
Arnoletti, J. Pablo
Behrman, Stephen W.
Ben-Josef, Edgar
Benson, Al B., III
Casper, Ephraim S.
Cohen, Steven J.
Czito, Brian
Ellenhorn, Joshua D. I.
Hawkins, William G.
Herman, Joseph
Hoffman, John P.
Ko, Andrew
Komanduri, Srinadh
Koong, Albert
Ma, Wen Wee
Malafa, Mokenge P.
Merchant, Nipun B.
Mulvihill, Sean J.
Muscarella, Peter, II
Nakakura, Eric K.
Obando, Jorge
Pitman, Martha B.
Sasson, Aaron R.
Tally, Anitra
Thayer, Sarah R.
Whiting, Samuel
Wolff, Robert A.
Wolpin, Brian M.
Freedman-Cass, Deborah A.
Shead, Dorothy A.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (06): : 703 - 713
[47] Systemic Mastocytosis, Version 3.2024: Featured Updates to the NCCN Guidelines
Gotlib, Jason
Gerds, Aaron T.
Abdelmessieh, Peter
Ali, Haris
Castells, Mariana
Dunbar, Andrew
Revell, Ruth Fein
George, Tracy I.
Green, Steven
Gundabolu, Krishna
Hexner, Elizabeth
Jain, Tania
Jamieson, Catriona
Kaesberg, Paul R.
Kuykendall, Andrew T.
Madanat, Yazan
Manchanda, Naveen
Masarova, Lucia
May, Jori
McMahon, Brandon
Mohan, Sanjay R.
Nadiminti, Kalyan V.
Oh, Stephen
Palmer, Jeanne
Patel, Ami
Patel, Anand A.
Podoltsev, Nikolai
Rein, Lindsay
Salit, Rachel
Talpaz, Moshe
Wadleigh, Martha
Wall, Sarah
Bergman, Mary Anne
Hochstetler, Cindy
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (2D):
[48] Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines
Mohler, James L.
Armstrong, Andrew J.
Bahnson, Robert R.
D'Amico, Anthony Victor
Davis, Brian J.
Eastham, James A.
Enke, Charles A.
Farrington, Thomas A.
Higano, Celestia S.
Horwitz, Eric M.
Hurwitz, Michael
Kane, Christopher J.
Kawachi, Mark H.
Kuettel, Michael
Lee, Richard J.
Meeks, Joshua J.
Penson, David F.
Plimack, Elizabeth R.
Pow-Sang, Julio M.
Raben, David
Richey, Sylvia
Roach, Mack, III
Rosenfeld, Stan
Schaeffer, Edward
Skolarus, Ted A.
Small, Eric J.
Sonpavde, Guru
Srinivas, Sandy
Strope, Seth A.
Tward, Jonathan
Shead, Dorothy A.
Freedman-Cass, Deborah A.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (01): : 19 - 30
[49] Kidney Cancer, Version 2.2020 Featured Updates to the NCCN Guidelines
Motzer, Robert J.
Jonasch, Eric
Michaelson, M. Dror
Nandagopal, Lakshminarayanan
Gore, John L.
George, Saby
Alva, Ajjai
Haas, Naomi
Harrison, Michael R.
Plimack, Elizabeth R.
Sosman, Jeffrey
Agarwal, Neeraj
Bhayani, Sam
Choueiri, Toni K.
Costello, Brian A.
Derweesh, Ithaar H.
Gallagher, Thomas H.
Hancock, Steven L.
Kyriakopoulos, Christos
LaGrange, Chad
Lam, Elaine T.
Lau, Clayton
Lewis, Bryan
Manley, Brandon
McCreery, Brittany
McDonald, Andrew
Mortazavi, Amir
Pierorazio, Phillip M.
Ponsky, Lee
Redman, Bruce G.
Somer, Bradley
Wile, Geoffrey
Dwyer, Mary A.
Hammond, Lydia J.
Zuccarino-Catania, Griselda
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1279 - 1285
[50] Multiple Myeloma, Version 3.2016 Featured Updates to the NCCN Guidelines
Anderson, Kenneth C.
Alsina, Melissa
Atanackovic, Djordje
Biermann, J. Sybil
Chandler, Jason C.
Costello, Caitlin
Djulbegovic, Benjamin
Fung, Henry C.
Gasparetto, Cristina
Godby, Kelly
Hofmeister, Craig
Holmberg, Leona
Holstein, Sarah
Huff, Carol Ann
Kassim, Adetola
Krishnan, Amrita Y.
Kumar, Shaji K.
Liedtke, Michaela
Lunning, Matthew
Raje, Noopur
Reu, Frederic J.
Singhal, Seema
Somlo, George
Stockerl-Goldstein, Keith
Treon, Steven P.
Weber, Donna
Yahalom, Joachim
Shead, Dorothy A.
Kumar, Rashmi
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (04): : 389 - 400

← 1 2 3 4 5 →